1. Pattabiraman DR, Weinberg RA. Tackling the cancer stem cells - what challenges do they pose? Nat Rev Drug Discov 2014;13:497-512.
2. Medema JP. Cancer stem cells: the challenges ahead. Nat Cell Biol 2013;15:338-44.
3. Cojoc M, Mäbert K, Muders MH, Dubrovska A. A role for cancer stem cells in therapy resistance: cellular and molecular mechanisms. Semin Cancer Biol 2015;31:16-27.
4. Cukierman E, Bassi DE. The mesenchymal tumor microenvironment: a drug-resistant niche. Cell Adh Migr 2012;6:285-96.
5. Borovski T, Beke P, van Tellingen O, Rodermond HM, Verhoeff JJ, et al. Therapy-resistant tumor microvascular endothelial cells contribute to treatment failure in glioblastoma multiforme. Oncogene 2013;32:1539-48.
6. Borovski T, De Sousa E Melo F, Vermeulen L, Medema JP. Cancer stem cell niche: the place to be. Cancer Res 2011;71:634-9.
7. LaBarge MA. The difficulty of targeting cancer stem cell niches. Clin Cancer Res 2010;16:3121-9.
8. Chen L, Kasai T, Li Y, Sugii Y, Jin G, et al. A model of cancer stem cells derived from mouse induced pluripotent stem cells. PLoS One 2012;7:e33544.
9. Yan T, Mizutani A, Chen L, Takaki M, Hiramoto Y, et al. Characterization of cancer stem-like cells derived from mouse induced pluripotent stem cells transformed by tumor-derived extracellular vesicles. J Cancer 2014;5:572-84.
10. Prieto-Vila M, Yan T, Calle AS, Nair N, Hurley L, et al. iPSC-derived cancer stem cells provide a model of tumor vasculature. Am J Cancer Res 2016;6:1906-21.
11. Matsuda S, Yan T, Mizutani A, Sota T, Hiramoto Y, et al. Cancer stem cells maintain a hierarchy of differentiation by creating their niche. Int J Cancer 2014;135:27-36.
12. Yan T, Mizutani A, Matsuda S, Murakami H, et al. Mutual dependence between cancer stem cells and their progenies: the niche created by the progenies is sustaining cancer stem cells. Cancer Cell & Microenvironment 2014;1:4.
13. Krishnamurthy S, Dong Z, Vodopyanov D, Imai A, Helman JI, et al. Endothelial cell-initiated signaling promotes the survival and self-renewal of cancer stem cells. Cancer Res 2010;70:9969-78.
14. Zhu TS, Costello MA, Talsma CE, Flack CG, Crowley JG, et al. Endothelial cells create a stem cell niche in glioblastoma by providing NOTCH ligands that nurture self-renewal of cancer stem-like cells. Cancer Res 2011;71:6061-72.
15. Calabrese C, Poppleton H, Kocak M, Hogg TL, Fuller C, et al. A perivascular niche for brain tumor stem cells. Cancer Cell 2007;11:14.
16. Ghajar CM, Peinado H, Mori H, Matei IR, Evason KJ, et al. The perivascular niche regulates breast tumour dormancy. Nat Cell Biol 2013;15:807-17.
17. Jeon HM, Kim SH, Jin X, Park JB, Joshi K, et al. Crosstalk between glioma-initiating cells and endothelial cells drives tumor progression. Cancer Res 2014;74:4482-92.
18. Okita K, Ichisaka T, Yamanaka S. Generation of germline-competent induced pluripotent stem cells. Nature 2007;448:313-7.
19. Nitiss JL. Targeting DNA topoisomerase II in cancer chemotherapy. Nat Rev Cancer 2009;9:338-50.
20. Nakajima W, Tanaka N. Noxa induces apoptosis in oncogene-expressing cells through catch-and-release mechanism operating between Puma and Mcl-1. Biochem Biophys Res Commun 2011;413:643-8.
21. Li M, He Y, Dubois W, Wu X, Shi J, et al. Distinct regulatory mechanisms and functions for p53-activated and p53-repressed DNA damage response genes in embryonic stem cells. Mol Cell 2012;46:30-42.
22. Lin T, Chao C, Saito S, Mazur SJ, Murphy ME, et al. p53 induces differentiation of mouse embryonic stem cells by suppressing Nanog expression. Nat Cell Biol 2005;7:165-71.
23. Enari M, Sakahira H, Yokoyama H, Okawa K, Iwamatsu A, et al. A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature 1998;391:43-50.
24. Wolf BB, Schuler M, Echeverri F, Green DR. Caspase-3 is the primary activator of apoptotic DNA fragmentation via DNA fragmentation factor-45/inhibitor of caspase-activated DNase inactivation. J Biol Chem 1999;274:30651-6.
25. McIlroy D, Sakahira H, Talanian RV, Nagata S. Involvement of caspase 3-activated DNase in internucleosomal DNA cleavage induced by diverse apoptotic stimuli. Oncogene 1999;18:4401-8.
26. Tichy ED, Stephan ZA, Osterburg A, Noel G, Stambrook PJ. Mouse embryonic stem cells undergo charontosis, a novel programmed cell death pathway dependent upon cathepsins, p53, and EndoG, in response to etoposide treatment. Stem Cell Res 2013;10:428-41.
27. Li LY, Luo X, Wang X. Endonuclease G is an apoptotic DNase when released from mitochondria. Nature 2001;412:95-9.
28. Alexander YG, Wang G, Bogdan SA, Cynthia S-RM, Mark SE, et al. Role of DNAS1L3 in Ca2+- and Mg2+-dependent cleavage of DNA into oligonucleosomal and high molecular mass fragments. Nucleic Acids Research 1999;27:1999-2005.
29. Yakovlev AG, Wang G, Stoica BA, Boulares HA, Spoonde AY, et al. A role of the Ca2+/Mg2+-dependent endonuclease in apoptosis and its inhibition by Poly(ADP-ribose) polymerase. J Biol Chem 2000;275:21302-8.
30. Boulares AH, Zoltoski AJ, Contreras FJ, Yakovlev AG, Yoshihara K, et al. Regulation of DNAS1L3 endonuclease activity by poly(ADP-ribosyl)ation during etoposide-induced apoptosis. Role of poly(ADP-ribose) polymerase-1 cleavage in endonuclease activation. J Biol Chem 2002;277:372-8.
31. Shiokawa D, Shika Y, Araki S, Sunaga S, Mizuta R, et al. Stage-specific expression of DNasegamma during B-cell development and its role in B-cell receptor-mediated apoptosis in WEHI-231 cells. Cell Death Differ 2007;14:992-1000.
32. Widlak P, Garrard WT. Ionic and cofactor requirements for the activity of the apoptotic endonuclease DFF40/CAD. Mol Cell Biochem 2001;218:125-30.
33. Wang R, Chadalavada K, Wilshire J, Kowalik U, Hovinga KE, et al. Glioblastoma stem-like cells give rise to tumour endothelium. Nature 2010;468:829-33.
34. Ricci-Vitiani L, Pallini R, Biffoni M, Todaro M, Invernici G, et al. Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells. Nature 2010;468:824-8.
35. Soda Y, Marumoto T, Friedmann-Morvinski D, Soda M, Liu F, et al. Transdifferentiation of glioblastoma cells into vascular endothelial cells. Proc Natl Acad Sci U S A 2011;108:4274-80.
36. Nagata S. Apoptotic DNA fragmentation. Exp Cell Res 2000;256:12-8.
37. Zhu J, Dou Z, Sammons MA, Levine AJ, Berger SL. Lysine methylation represses p53 activity in teratocarcinoma cancer cells. Proc Natl Acad Sci U S A 2016;113:9822-7.
38. Lutzker SG, Levine AJ. A functionally inactive p53 protein in teratocarcinoma cells is activated by either DNA damage or cellular differentiation. Nat Med 1996;2:804-10.
39. Wang YH, Scadden DT. Harnessing the apoptotic programs in cancer stem-like cells. EMBO Rep 2015;16:1084-98.
40. Zachara NE, Molina H, Wong KY, Pandey A, Hart GW. The dynamic stress-induced “O-GlcNAc-ome” highlights functions for O-GlcNAc in regulating DNA damage/repair and other cellular pathways. Amino Acids 2011;40:793-808.
41. Miura Y, Sakurai Y, Endo T. O-GlcNAc modification affects the ATM-mediated DNA damage response. Biochim Biophys Acta 2012;1820:1678-85.
42. Johnson B, Opimba M, Bernier J. Implications of the O-GlcNAc modification in the regulation of nuclear apoptosis in T cells. Biochim Biophys Acta 2014;1840:191-8.
43. Speakman CM, Domke TC, Wongpaiboonwattana W, Sanders K, Mudaliar M, et al. Elevated O-GlcNAc levels activate epigenetically repressed genes and delay mouse ESC differentiation without affecting naïve to primed cell transition. Stem Cells 2014;32:2605-15.
44. Pang B, Qiao X, Janssen L, Velds A, Groothuis T, et al. Drug-induced histone eviction from open chromatin contributes to the chemotherapeutic effects of doxorubicin. Nat Commun 2013;4:1908.
45. Arnoult D, Gaume B, Karbowski M, Sharpe JC, Cecconi F, et al. Mitochondrial release of AIF and EndoG requires caspase activation downstream of Bax/Bak-mediated permeabilization. EMBO J 2003;22:4385-99.
46. Guo W, Zhang Y, Ling Z, Liu X, Zhao X, et al. Caspase-3 feedback loop enhances Bid-induced AIF/endoG and Bak activation in Bax and p53-independent manner. Cell Death Dis 2015;6:e1919.
47. Calle AS, Nair N, Oo AK, Prieto-Vila M, Koga M, et al. A new PDAC mouse model originated from iPSCs-converted pancreatic cancer stem cells (CSCcm). Am J Cancer Res 2016;6:2799-815.
48. Nair N, Calle AS, Zahra MH, Prieto-Vila M, Oo AKK, et al. A cancer stem cell model as the point of origin of cancer-associated fibroblasts in tumor microenvironment. Sci Rep 2017;7:6838.
Comments
Comments must be written in English. Spam, offensive content, impersonation, and private information will not be permitted. If any comment is reported and identified as inappropriate content by OAE staff, the comment will be removed without notice. If you have any queries or need any help, please contact us at support@oaepublish.com.